Table 1.
Amoebic abscess | Pyogenic abscess | |
---|---|---|
Pathogen | Entamoeba histolytica | Klebsiella pneumoniae, Streptococcus milleri, Escheria coli, Burkholderia pseudomallei, Staphylococcus aureus, Polymicrobial including anaerobes |
Distribution | Globally, higher rates in LMICs, typically males 30–50 years | Globally, older patients |
Acquisition | Poor sanitation, contaminated drinking water | Biliary source, e.g. impacted gall stone Systemic infection |
Pathogenesis | Inflammation—abundant neutrophils | Necrosis—absence of neutrophils |
Imaging | Usually single (can be multiple) Typically in right lobe (can be in left lobe) Cold appearance on sulfur colloid scan |
Either single or multiple Any lobe can be involved Hot appearance on sulfur colloid scan |
Fine needle aspirate | Macroscopic—thick, chocolate brown, odourless, ‘anchovy paste’ Microscopy for trophozoites—insensitive (25%) Antigen testing—sensitive and specific, generally not available in LMICs PCR—sensitive and specific, generally not available in LMICs |
Macroscopic—purulent, may be foul smelling Culture—limited availability in LMICs |
Other diagnostic modalities | Serology—useful in returned travelers, limited role in residents of high endemicity Antigen testing of serum—sensitive and specific, generally not available in LMICs |
Blood cultures—sensitivity 50%, limited availability in LMICs, in LMICs patients often pre-treated with antimicrobials prior to specimen collection. |
Treatment | Medical therapy with metronidazole usually sufficient. (May require drainage in co-infection or impending rupture.) | Percutaneous drainage along with antibiotics is mainstay of therapy. Antibiotic treatment in small responsive abscesses. |